Health & Medicine
Pharma Flop: Eli Lilly's Alzheimer Cure Fails Drug Trials
Eli Lilly and Co.’s promising pharmaceutical drug for memory-fading disease, Alzheimer’s, has failed its large clinical trial. According to the company’s official statement, patients treated with solanezumab did not experience a statistically significant slowing in cognitive decline compared to patients treated with placebo.
Latest Research Articles
Scientist On the Verge of Making Human Regeneration Possible
Father's Involvement Linked to Improvement in Child's Performance, Study Finds
190,000 Birds Euthanized in the Netherlands to Avoid Bird Flu Outbreak
Bringing Nature Inside the Workplace Boosts Productivity, Scientists Say
Athos to Introduce Personal 'Training' Fitness Clothes
Tropical Bedbug Species Reappear in the US
Dogs on Weed? Pet Owners Using Cannabis-Based Products to Treat Animal Ailments on the Rise
First HIV Vaccine Trials to Begin in South Africa
Thunderstorm Asthma: What Is It and Why Does It Happen
Weight Loss News: Gut Microbes Affect Chance of Obesity
Studies Show Fewer Americans Want to Lose Weight
Fear Factor: Scientists Discover a Way to Remove Fear From the Brain
MOST POPULAR
-
Met Office Issues Warning About Thunderstorms And Flooding: Are They Coming To A Place Near You?
-
New World Screwworm Discovered For The First Time In The US: Is An Outbreak Of 'Human-Eating' Parasite Imminent?
-
Are Orcas Friendly to Humans? Killer Whales Mysteriously Attack Boats in Portugal, Even Sinking One
-
Bangkok Sink Hole Shocks The World: Here Are Other Deadly Incidents That Happened And Why
-
Orca Attack Video: Yacht Sinks In Portugal In Viral Clip - How Strong Are These Ocean Predators?
